JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Even-Sapir, E.
Right arrow Articles by Nakache, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Even-Sapir, E.
Right arrow Articles by Nakache, R.
Journal of Nuclear Medicine Vol. 43 No. 5 584-588
© 2002 by Society of Nuclear Medicine

Clinical Investigations

Kidney Allografts and Remaining Contralateral Donor Kidneys Before and After Transplantation: Assessment by Quantitative 99mTc-DMSA SPECT

Einat Even-Sapir, MD, DSc1, Mordechai Gutman, MD2, Hedva Lerman, MD1, Eli Kaplan, MD2, Anat Ravid, MD2, Genady Livshitz, MD1 and Richard Nakache, MD2

1 Department of Nuclear Medicine, Tel-Aviv Sourasky Medical Center, Tel-Aviv University, Tel-Aviv, Israel
2 Organ Transplantation Unit, Department of Surgery "B," Tel-Aviv Sourasky Medical Center, Tel-Aviv University, Tel-Aviv, Israel


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 CONCLUSION
 REFERENCES
 
We used 99mTc-dimercaptosuccinic acid (DMSA) quantitative SPECT (QDMSA) to assess the function of kidneys before harvesting and after transplantation as well as the function of remaining donor kidneys. Methods: Nineteen kidney donors underwent a baseline QDMSA study before nephrectomy. The allografts of these kidneys were studied in recipients at 1 wk, 1–2 mo, and 6–15 mo after transplantation. The kidneys remaining in 16 donors were studied at 1–2 mo and 6–15 mo after harvesting. The parameters obtained in each SPECT study included functional volume, concentration of 99mTc-DMSA per cubic centimeter of renal tissue, and total kidney uptake. Clinical evaluation and determination of serum creatinine levels took place at the same time as SPECT. Results: On the basis of the clinical evaluation, 14 grafts had normal function and 5 were impaired. The mean ± SD of kidney uptake values expressed as percentage of baseline values were 131% ± 30% in normal grafts versus 57% ± 5% in impaired grafts at 1 wk (P < 0.01), 173% ± 57% versus 65% ± 10% at 1–2 mo (P < 0.001), and 190% ± 50% versus 69% ± 14% at 6–15 mo after transplantation (P < 0.01). Uptake values in the donors’ remaining kidneys were 159% ± 27% of baseline values at 1–2 mo and 164% ± 30% at 6–15 mo after nephrectomy. Allografts and remaining kidneys showed a similar increase in total kidney uptake as a result of an increase in both functional volume and concentration. Conclusion: QDMSA may be a noninvasive assessment tool in kidney transplantation from living donors.

Key Words: transplantation • SPECT • 99mTc-dimercaptosuccinic acid


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 CONCLUSION
 REFERENCES
 
Dimercaptosuccinic acid (DMSA) labeled with 99mTc is a renal cortical agent that detects the functioning proximal tubular mass. Its uptake correlates with effective renal plasma flow, glomerular filtration rate, and creatinine clearance. Its quantitative measurement is therefore a good index for renal function. Previous studies have shown that 99mTc-DMSA uptake differentiates between normal and diseased kidneys (1–3).

A quantitative SPECT technique has been described by Iosilevsky et al. for in vivo quantitation of radiopharmaceutical concentration and organ volume (4). Previous studies have applied this technique for assessment of kidney function using 99mTc-DMSA as the injected radiopharmaceutical. A good correlation was found between quantitative SPECT 99mTc-DMSA total kidney uptake and creatinine clearance in patients with a single kidney. The technique was used for assessment of the adaptive changes occurring in functioning kidneys remaining after nephrectomy and was reproducible, with differences of <10% having been observed in healthy volunteers in repeated studies (5–8). Quantitative 99mTc-DMSA SPECT (QDMSA) appears to be a practical noninvasive technique for monitoring changes in individual renal volume and function on follow-up.

An accurate determination of renal mass and function is critical both before transplantation for kidney donor selection and after transplantation for follow-up. In this study, we assessed the potential role of QDMSA in the clinical setting of renal transplantation. The remaining donor kidney and the donated kidney were evaluated before and after transplantation.


   MATERIALS AND METHODS
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
RESULTS
 DISCUSSION
 CONCLUSION
 REFERENCES
 
Patients
Paired kidneys from 19 consecutive living donors (8 men, 11 women; age range, 24–71 y; mean age, 41 ± 13 y) were analyzed before nephrectomy (13–56 d; mean, 26.4 ± 14 d) by a QDMSA scan, which served as a baseline study. The kidneys were transplanted in 19 recipients (10 men, 9 women; age range, 20–55 y; mean age, 40 ± 10 y). All allografts were analyzed 1–2 mo after transplantation. Eight allografts were analyzed also at 1 wk after transplantation, and 12 allografts were analyzed at 1 y after surgery. The scintigraphic findings were correlated with clinical outcome and with serum creatinine levels measured at the time of the QDMSA study. The remaining kidney after nephrectomy was studied in 16 donors at 1–2 mo after harvesting and, in 10 of these donors, also at 6–15 mo after surgery.

QDMSA
SPECT scintigraphy of the kidneys was performed 4 h after intravenous injection of 148 MBq (4 mCi) 99mTc-DMSA using either single-head or double-headed rotating cameras with all-purpose parallel-hole collimators. Data acquisition lasted 20 min and yielded 120 projections, 3° apart, in a matrix size of 64 x 64. The total number of counts per study was 3–5 x 105. Data were reconstructed by the filtered backprojection technique using a Hanning filter with a cutoff of 0.5 cycle per centimeter. Reconstructed images were displayed in transaxial, coronal, and sagittal slices with a slice thickness of 1 pixel (0.68 cm in the 64 x 64 matrix size used). The exact injection dose required for quantitation was obtained by measuring the syringe uptake immediately before and after injection, and a decay correction from time of injection to time of scintigraphy was performed.

The 99mTc-DMSA concentration and functional volume of the kidney were quantified using a quantitative SPECT technique that has been described previously in detail (4,9). The method uses an empiric threshold value to separate target from background pixels. The operator selects the reconstructed slices containing the entire functioning kidney tissue that takes up 99mTc-DMSA. The pixel that contains the maximal number of counts within the kidney is selected by the computer, and the threshold value is expressed as a percentage of the counts within the pixel. The threshold value suitable for 99mTc-DMSA measurements was empirically obtained by phantom studies and by in vivo measurements versus in vitro measurements in humans and was found to be 43% (4,5). Only nonzero pixels (activity greater than threshold) are used for volume and concentration measurements. The functional volume (cubic centimeters) is defined as the total number of nonzero pixels multiplied by the slice thickness (1 pixel). Concentration is defined as the percentage of injected dose (%ID) corrected for decay per cubic centimeter of kidney tissue. The total kidney uptake was obtained by multiplying volume by concentration. Functional volume, concentration, and kidney uptake were the 3 parameters used in the results analysis.

Statistical Analysis
The results (mean ± SD) for volume, concentration, and uptake in allografts were expressed as percentage of baseline values before harvesting. Normal functioning allografts were compared with impaired allografts. Normal functioning allografts were also compared with the remaining contralateral single kidneys in donors. The comparisons were made using an unpaired t test. The significance of the change in actual concentration, volume, and uptake (concentration x volume) values of kidneys before harvesting and after transplantation was assessed using a paired t test. P < 0.05 was considered statistically significant.


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
DISCUSSION
 CONCLUSION
 REFERENCES
 
Transplanted Kidneys
On the basis of clinical outcome and blood creatinine levels measured at the time of the SPECT studies, 14 allografts had normal function (group A) and 5 had impaired function (group B).

Comparison Between Kidneys Before Harvesting and After Transplantation.
The concentration measured in group A allografts was significantly higher after transplantation than before harvesting (P < 0.01, t = 3.34). In group B, the concentration was lower after transplantation than before harvesting. The difference, however, was not of statistical significance, probably because of the small group size. The volume of group A allografts was higher after transplantation than before harvesting (208 ± 35 cm3 vs. 256 ± 46 cm3, P < 0.001, t = 4.5). An increase in volume was also measured in group B allografts but was not of statistical significance, probably because of the small group size (159 ± 20 cm3 vs. 219 ± 71 cm3). The total kidney uptake value (concentration x volume) after transplantation, compared with that before harvesting, was significantly higher in group A (22.5% ± 7% vs. 13.4% ± 3.5%, P < 0.001, t = 5.07) and significantly lower in group B (8% ± 0.9% vs. 13.5% ± 2.6%, P < 0.01, t = 5.58).

Comparison Between Normal and Impaired Allografts.
Table 1 summarizes the comparison of total kidney uptake in normal and impaired allografts. Normal allografts had a significantly higher uptake at all times after transplantation. The concentration of 99mTc-DMSA was 60% ± 16% of baseline values in group B allografts and 131% ± 55% of baseline values in group A allografts (P < 0.05, t = 2.42) at 1–2 mo after transplantation. Group A and B allografts showed a similar increase in kidney volume relative to baseline measurements: 125% ± 35% in impaired allografts and 128% ± 23% in normal allografts.


View this table:
[in this window]
[in a new window]
  		TABLE 1 99mTc-DMSA Total Kidney Uptake in Normal and Impaired Allografts

 
Remaining Contralateral Donor Kidneys
Uptake values in the remaining donor kidneys were 159% ± 27% (range, 108%–208%) of baseline values at 1–2 mo after nephrectomy and 164% ± 30% (range, 120%–206%) at 6–15 mo. Uptake values in these remaining kidneys at 1–2 mo after nephrectomy were 82% ± 11% (range, 60%–99%) of the total uptake measured in both kidneys before nephrectomy.

Table 2 and Figure 1 summarize the uptake, functional volume, and concentration of 99mTc-DMSA in normal functioning single kidneys, which included normal allografts (n = 14) and remaining donor kidneys (n = 16). Uptake values measured in normal functioning allografts and remaining donor kidneys did not differ significantly either at 1–2 mo or at 6–15 mo after surgery. Both allografts and remaining donor kidneys showed an increase in volume relative to the volume measured before harvesting. Allografts showed a higher increase in volume than did remaining donor kidneys at 1–2 mo after surgery (125% ± 19% vs. 109% ± 11%, P < 0.01, t = 2.77). A sizable hematoma was probably the cause for the single normal allograft that decreased in volume compared with the baseline volume measured before harvesting. At 6–15 mo after surgery, allografts and donor kidneys showed a similar increase in volume relative to baseline values (121% ± 17% and 120% ± 14%, respectively). Allografts and remaining donor kidneys also showed a similar increase in the concentration of 99mTc-DMSA per cubic centimeter, compared with the concentration in remaining donor kidneys, at 1–2 mo and 6–15 mo after surgery.


View this table:
[in this window]
[in a new window]
  		TABLE 2 QDMSA Results in Normal Allografts and in Donors’ Remaining Kidneys After Nephrectomy

 


View larger version (28K):
[in this window]
[in a new window]
  		FIGURE 1. Comparison of total kidney uptake, concentration, and volume of 99mTc-DMSA in normal allografts and in donors’ remaining kidneys early (1–2 mo) and late (6–15 mo) after transplantation. ns = not statistically significant.

 

   DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
CONCLUSION
 REFERENCES
 
Nephron mass and renal function have a major impact on the long-term outcome of kidney transplantation. Their accurate determination is essential both in selection of kidneys for donation and in monitoring of transplantation results. After renal transplantation, patients are often evaluated with radionuclide renal function studies and sonography. The goal of these studies is, however, mainly to assess whether possible complications such as ischemic damage, acute tubular necrosis, and urine leakage are present. Sequential radionuclide function studies may provide data on effective renal plasma flow, excretory index, and glomerular filtration rate, parameters that change when the graft is diseased or responding to treatment (10–12). These function studies were also suggested as predictors for survival of cadaver grafts, which are frequently associated with acute tubular necrosis, but not of living related donor grafts, which only infrequently have this complication (12). These measurements may be labor intensive, and for more accurate assessment, the external measurement of renal activity should be supplemented by laboratory measurements of blood and urine. Some publications suggest that the indication for serial scintigraphic monitoring for grafts is even less certain (13).

In the current study, we assessed the potential use of a practical, noninvasive quantitative SPECT technique (QDMSA) in the clinical setting of living related donor kidney transplantation. The parameters determined using this technique included functional kidney volume and the concentration of the cortical agent 99mTc-DMSA per gram of tissue (4). The total kidney 99mTc-DMSA uptake obtained by multiplying these 2 parameters is an index of renal function and has been shown to correlate with effective renal plasma flow, glomerular filtration rate, and creatinine clearance (1–3,5). The technique is reproducible, and differences of <10% were observed in healthy volunteers in repeated studies (8). It is, therefore, suitable for serial monitoring of renal function as well.

Kidney donors underwent QDMSA studies, and the function and volume values measured before harvesting were used as points of references for assessing changes associated with kidney harvesting and transplantation. Total 99mTc-DMSA uptake was significantly different in normal functioning and impaired allografts. Normal functioning allografts maintained their function immediately after transplantation and by 1 mo had already gained compensatory uptake values of 173% ± 57% of the baseline values before harvesting. In contrast, impaired grafts failed to achieve the uptake values that were measured before transplantation and did not improve significantly with time. These results suggest that uptake measured as early as 1 wk after transplantation can predict future graft function.

The change in concentration and uptake found in normal allografts resembled that found in single kidneys remaining in the donor; that is, both types of single kidneys, the donated transplanted kidney and the remaining contralateral kidney, showed a compensatory increase in function compared with their function before the transplantation. Kidney transplants reached even higher functional volumes early after transplantation than did the remaining donor kidneys. These findings most likely reflect relatively rapid compensatory mechanisms similar to those suggested in animals after nephrectomy and agree with human studies that have shown that, although renal mass is halved after uninephrectomy, the glomerular filtration rate increases to 70%–78% of the preoperative value within days to weeks. The level of renal function stabilizes and is maintained without any demonstrable decline in function (7,14–20). Essential to this end, however, is proper selection of donors and kidneys. Measurement of functional volume in potential donor kidneys might have an important role in the selection process before kidney transplantation, because the functioning nephron mass is a major factor in transplantation outcome (21–25). In the routine search for kidney donors, selection of suitable kidneys usually depends on donor age, disease history, blood and urine findings, and, occasionally, sonography findings and on tests assessing the function of each kidney separately, such as split renal function testing. The QDMSA technique presented here noninvasively and quantitatively assesses the function and volume of individual kidneys.


   CONCLUSION
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 CONCLUSION
REFERENCES
 
QDMSA may be a noninvasive assessment tool for kidney transplantation from living donors. Potential uses in this setting may include selection of donor kidneys with a suitable functioning mass, early assessment of transplantation results, and monitoring of changes in the kidneys of both donors and recipients.


   ACKNOWLEDGMENTS
 
The authors thank Esther Eshkol for editorial assistance.


   FOOTNOTES
 
Received Aug. 7, 2001; revision accepted Jan. 16, 2002.

For correspondence or reprints contact: Einat Even-Sapir, MD, DSc, Department of Nuclear Medicine, Tel-Aviv Sourasky Medical Center, 6 Weizman St., Tel-Aviv 64239, Israel.

E-mail: evensap{at}tasmc.health.gov.il


   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 CONCLUSION
 REFERENCES
 

  1. Tailor A. Quantitation of renal function with static imaging agents. Semin Nucl Med. 1982; 12: 330–344.[Medline]
  2. Kawamura J, Hosokawa S, Yoshida O, Fujita T, Ishi Y, Torisuka K. Validity of 99m-Tc dimercaptosuccinic acid renal uptake for an assessment of individual kidney function. J Urol. 1978; 119: 305–309.[Medline]
  3. Daly MJ, Jones W, Rudd TG, Tremann J. Differential renal function using technetium-99m-dimercaptosuccinic acid (DMSA): in vitro correlation. J Nucl Med. 1979; 20: 63–66.[Abstract/Free Full Text]
  4. Iosilevsky G, Israel O, Frankel A, et al. A practical SPECT technique for quantitation of drug delivery to human tumors and organ absorbed radiation dose. Semin Nucl Med. 1989; 19: 33–46.[Medline]
  5. Groshar D, Frankel A, Iosilevsky G, et al. Quantitation of renal uptake of technetium-99m DMSA using SPECT. J Nucl Med. 1989; 30: 246–250.[Abstract/Free Full Text]
  6. Groshar D, Embon OM, Frankel A, Front D. Renal function and Tc-99m-DMSA uptake in single kidneys: the value of in vivo SPECT quantitation. J Nucl Med. 1991; 322: 766–768.
  7. Ben-Haim S, Sopov V, Stein A, et al. Kidney function after radical nephrectomy: assessment by quantitative SPECT of 99mTc-DMSA uptake by the kidneys. J Nucl Med. 2000; 41: 1025–1029.[Abstract/Free Full Text]
  8. Groshar D, Moskovitz B, Issaq E, Nativ O. Quantitative SPECT of DMSA uptake by the kidneys: assessment of reproducibility. Kidney Int. 1997; 52: 817–820.[Medline]
  9. Even-Sapir E, Bar-Shalom R, Israel O, et al. Single photon emission computed tomography quantitation of gallium citrate uptake for the differentiation of lymphoma from benign hilar uptake. J Clin Oncol. 1995; 13: 942–946.[Abstract]
  10. Dubovsky EV, Russell CD. Radionuclide evaluation of renal transplantation. Semin Nucl Med. 1998; 3: 181–198.
  11. Li Y, Russell CD, Palmer-Laurence J, Dubovsky E. Quantitation of renal parenchymal retention of technetium-99m-MAG3 in renal transplants. J Nucl Med. 1994; 35: 846–850.[Abstract/Free Full Text]
  12. Russell CD, Yang H, Gaston RS, Hudson SL, Diethelm AG, Dubovsky E. Prediction of renal transplant survival from early postoperative radioisotope studies. J Nucl Med. 2000; 41: 1332–1336.[Abstract/Free Full Text]
  13. Heaf JG, Iversen J. Uses and limitations of renal scintigraphy in renal transplantation monitoring. Eur J Nucl Med. 2000; 7: 871–879.
  14. Threlfall G, Cairnie A, Taylor D. Renal compensatory hypertrophy in the rat. Biochem J. 1964; 90: 6p–7p.
  15. Wesson LG. Compensatory growth and other growth responses of the kidneys. Nephron 1989; 51: 149–184.[Medline]
  16. Terasaki PI, Koyama H, Cecka JM, Gjertson DW. The hyperfiltration hypothesis in human renal transplantation. Transplantation 1994; 57: 1450–1454.[Medline]
  17. Pabico RC, McKenna BA, Freeman BB. Renal function before and after unilateral nephrectomy in renal donors. Kidney Int 1975; 8: 165–175.
  18. Boner G, Shelp WD, Newton M, Reiselbach RE. Factors influencing increase in glomerular filtration rate in the remaining kidney of transplant donors. Am J Med. 1973; 55: 169–174.[Medline]
  19. George J, John GT, Oommen R, Jacob S, Jacob CK, Shastry JCM. Renal function reserve in kidney donors assessed in different settings using scintigraphy. Nephron 1996; 73: 154–157.[Medline]
  20. Vincenti F, Amend WJC, Kaysen G, et al. Long-term renal function in kidney donors. Transplantation 1983; 36: 626–629.[Medline]
  21. Mackenzie HS, Azuma H, Rennke HG, Tilney NL, Brenner BM. Renal mass as a determinant of late allograft outcome: insights from experimental studies in rats. Kidney Int Suppl. 1995; 52: 38s–42s.
  22. Miles AM, Sumrani N, John S, et al. The effect of kidney size on cadaveric allograft outcome. Transplantation 1996; 61: 894–897.[Medline]
  23. Brenner BM, Mackenzie HS. Nephron mass as a risk factor for progression of renal disease. Kidney Int Suppl. 1997; 63: 124s–127s.
  24. Azuma H, Nadeau K, Mackenzie HS, Brenner BM, Tilney NL. Nephron mass modulates the hemodynamics, cellular, and molecular response of the rat renal allograft. Transplantation 1997; 63: 519–528.[Medline]
  25. Johnson LB, Kuo PC, Dafoe DC, et al. The use of bilateral adult renal allografts: a method to optimize function from donor kidneys with suboptimal nephron mass. Transplantation 1996; 61: 1261–1277.[Medline]




This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Even-Sapir, E.
Right arrow Articles by Nakache, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Even-Sapir, E.
Right arrow Articles by Nakache, R.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE